Is a complete AUPH research report available?

No complete published report is available for Aurinia Pharmaceuticals Inc. (AUPH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · USD

$17.3

+0.08 (+0.5%)· Recorded snapshot

Market cap	2.3B
Revenue (ttm)	311.5M
Net income (ttm)	314.1M
EPS (ttm)	$2.30
Shares out	133.1M
P/E (trailing)	7.5x
P/E (forward)	20.7x
Volume	466,204
Beta	1.61

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001600620
Company name	Aurinia Pharmaceuticals Inc.
Country	Canada
Country code	US
CUSIP number	05156V102
Earnings date	2026-11-10
Earnings time	bmo
Employees	128
Employees change	-2
Employees growth	-1.54%
Enterprise value	$1.9B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1993
In index	RUSSELL2000
Industry	Biotechnology
IPO date	1999-01-26
Is primary listing	Yes
Is SPAC	No
ISIN number	CA05156V1022
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2013-10-23
Last stock split type	Reverse
Market cap	$2.3B
Market cap category	Mid-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$17.33
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	AUPH
Website	https://www.auriniapharma.com

Metric

Value

Amount currency

USD

CIK code

0001600620

Company name

Aurinia Pharmaceuticals Inc.

Country

Canada

Country code

CUSIP number

05156V102

Earnings date

2026-11-10

Earnings time

bmo

Employees

128

Employees change

-2

Employees growth

-1.54%

Enterprise value

$1.9B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1993

In index

RUSSELL2000

Industry

Biotechnology

IPO date

1999-01-26

Is primary listing

Yes

Is SPAC

ISIN number

CA05156V1022

Last 10-K release date

2026-02-26

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2013-10-23

Last stock split type

Reverse

Market cap

$2.3B

Market cap category

Mid-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$17.33

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

AUPH

Website

https://www.auriniapharma.com

Metric	Value
Adjusted P/E ratio	7.57x
Earnings yield	13.29%
EV/Earnings	6.06x
EV/EBIT	11.87x
EV/EBITDA	10.59x
EV/FCF	10.88x
EV/Sales	6.11x
FCF / EV yield	9.19%
FCF yield	7.67%
Forward EV/Sales	5.54x
Forward P/E	20.73x
Forward P/S	6.64x
Graham number	15.48367
Graham upside	-9.77%
P/(FCF - SBC) ratio	14.23x
P/(OCF - SBC) ratio	14.21x
P/B ratio	3.73x
P/E ratio	7.52x
P/FCF ratio	13.04x
P/OCF ratio	13.03x
P/S ratio	7.33x
Price / tangible book value	3.73x
Price/EBITDA ratio	12.7x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

7.57x

Earnings yield

13.29%

EV/Earnings

6.06x

EV/EBIT

11.87x

EV/EBITDA

10.59x

EV/FCF

10.88x

EV/Sales

6.11x

FCF / EV yield

9.19%

FCF yield

7.67%

Forward EV/Sales

5.54x

Forward P/E

20.73x

Forward P/S

6.64x

Graham number

15.48367

Graham upside

-9.77%

P/(FCF - SBC) ratio

14.23x

P/(OCF - SBC) ratio

14.21x

P/B ratio

3.73x

P/E ratio

7.52x

P/FCF ratio

13.04x

P/OCF ratio

13.03x

P/S ratio

7.33x

Price / tangible book value

3.73x

Price/EBITDA ratio

12.7x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	51.51%
EBITDA margin	57.73%
FCF margin	56.2%
Gross margin	77.88%
Operating margin	51.51%
Pretax margin	51.48%
Profit margin	100.84%
Profit per employee	$2.5M
Profitable quarters	9
Profitable years	2
Revenue per employee	$2.4M
ROA	15.49%
ROA (5Y)	-6.82%
ROCE	23.17%
ROE	66.12%
ROE (5Y)	-4.75%
ROIC	65%
SBC / revenue	4.69%
Tax / revenue	-49.36%

Metric

Value

EBIT margin

51.51%

EBITDA margin

57.73%

FCF margin

56.2%

Gross margin

77.88%

Operating margin

51.51%

Pretax margin

51.48%

Profit margin

100.84%

Profit per employee

$2.5M

Profitable quarters

Profitable years

Revenue per employee

$2.4M

ROA

15.49%

ROA (5Y)

-6.82%

ROCE

23.17%

ROE

66.12%

ROE (5Y)

-4.75%

ROIC

65%

SBC / revenue

4.69%

Tax / revenue

-49.36%

Metric	Value
EPS growth	447.94%
EPS growth (Q)	75.54%
EPS growth (QoQ)	12%
EPS growth quarters	10
EPS growth years	4
FCF growth	89.41%
FCF growth (Q)	19.08%
FCF growth (QoQ)	61.64%
Gross profit growth	16.12%
Gross profit growth (Q)	16.36%
Gross profit growth 3Y	31.1%
Gross profit growth 5Y	82.77%
Net income growth	418.03%
Net income growth (Q)	73.91%
Net income growth (QoQ)	8.9%
Net income growth quarters	10
Net income growth years	4
OCF growth	89.08%
OCF growth (Q)	18.82%
OCF growth (QoQ)	61.44%
Operating income growth	154.25%
Operating income growth (Q)	129.44%
Revenue growth	19.76%
Revenue growth (Q)	18.87%
Revenue growth (QoQ)	7.1%
Revenue growth 10Y	106.03%
Revenue growth 3Y	24.84%
Revenue growth 5Y	40.16%
Revenue growth quarters	11
Revenue growth years	4

Metric

Value

EPS growth

447.94%

EPS growth (Q)

75.54%

EPS growth (QoQ)

12%

EPS growth quarters

EPS growth years

FCF growth

89.41%

FCF growth (Q)

19.08%

FCF growth (QoQ)

61.64%

Gross profit growth

16.12%

Gross profit growth (Q)

16.36%

Gross profit growth 3Y

31.1%

Gross profit growth 5Y

82.77%

Net income growth

418.03%

Net income growth (Q)

73.91%

Net income growth (QoQ)

8.9%

Net income growth quarters

Net income growth years

OCF growth

89.08%

OCF growth (Q)

18.82%

OCF growth (QoQ)

61.44%

Operating income growth

154.25%

Operating income growth (Q)

129.44%

Revenue growth

19.76%

Revenue growth (Q)

18.87%

Revenue growth (QoQ)

7.1%

Revenue growth 10Y

106.03%

Revenue growth 3Y

24.84%

Revenue growth 5Y

40.16%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-176,000
Depreciation and amortization	$19.4M
EBIT	$160.4M
EBITDA	$179.8M
EPS	$2.30
FCF per share	$1.32
Financing cash flow	$-61.3M
Free cash flow	$175.1M
Free cash flow minus SBC	$160.4M
Gross profit	$242.6M
Income taxes	$-153.8M
Investing cash flow	$12.8M
Net borrowing	$-14M
Net cash flow	$126.8M
Net income	$314.1M
Operating cash flow minus SBC	$160.6M
Operating income	$160.4M
Revenue	$311.5M
Stock-based compensation	$14.6M

Metric

Value

Capital expenditures

$-176,000

Depreciation and amortization

$19.4M

EBIT

$160.4M

EBITDA

$179.8M

EPS

$2.30

FCF per share

$1.32

Financing cash flow

$-61.3M

Free cash flow

$175.1M

Free cash flow minus SBC

$160.4M

Gross profit

$242.6M

Income taxes

$-153.8M

Investing cash flow

$12.8M

Net borrowing

$-14M

Net cash flow

$126.8M

Net income

$314.1M

Operating cash flow minus SBC

$160.6M

Operating income

$160.4M

Revenue

$311.5M

Stock-based compensation

$14.6M

Metric	Value
Altman Z-Score	6.89
Book value per share	$4.63
Debt / EBITDA	0.36
Debt / equity	0.1
Debt / FCF	0.37
Interest coverage	39.08
Long-term assets	$250.9M
Long-term liabilities	$77.5M
Net cash (debt)	$378.9M
Net cash / market cap	16.59%
Net cash growth	62.46%
Net debt / EBITDA	-2.11
Net debt / equity	-0.62
Net debt / FCF	-2.16
Piotroski F-Score	4
Property, plant and equipment	$68.5M
Shareholders' equity	$614.9M
Tangible book value	$611.5M
Tangible book value per share	$4.60
Total assets	$792.3M
Total cash	$443M
Total debt	$64.1M
Total liabilities	$177.4M
WACC	12.89%

Metric

Value

Altman Z-Score

6.89

Book value per share

$4.63

Debt / EBITDA

0.36

Debt / equity

0.1

Debt / FCF

0.37

Interest coverage

39.08

Long-term assets

$250.9M

Long-term liabilities

$77.5M

Net cash (debt)

$378.9M

Net cash / market cap

16.59%

Net cash growth

62.46%

Net debt / EBITDA

-2.11

Net debt / equity

-0.62

Net debt / FCF

-2.16

Piotroski F-Score

Property, plant and equipment

$68.5M

Shareholders' equity

$614.9M

Tangible book value

$611.5M

Tangible book value per share

$4.60

Total assets

$792.3M

Total cash

$443M

Total debt

$64.1M

Total liabilities

$177.4M

WACC

12.89%

Metric	Value
Asset turnover	0.48
Current assets	$541.3M
Current liabilities	$99.9M
Current ratio	5.42
Inventory turnover	1.5
Net working capital	$16.6M
Quick ratio	4.86
Working capital	$441.4M
Working capital turnover	0.81

Metric

Value

Asset turnover

0.48

Current assets

$541.3M

Current liabilities

$99.9M

Current ratio

5.42

Inventory turnover

1.5

Net working capital

$16.6M

Quick ratio

4.86

Working capital

$441.4M

Working capital turnover

0.81

Metric	Value
Buyback yield / dilution	5.66%
Dividend yield	0%
Shareholder yield	5.66%

Metric

Value

Buyback yield / dilution

5.66%

Dividend yield

Shareholder yield

5.66%

Metric	Value
10Y price change	441.64%
10Y return CAGR	18.41%
10Y total return	441.64%
150-day SMA	$16.00
1D price change	0.46%
1M price change	4.44%
1M total return	4.44%
1W price change	2.57%
1W total return	2.57%
1Y price change	39.71%
1Y return CAGR	39.74%
1Y total return	39.71%
20-day SMA	$16.53
200-day SMA	$15.63
3M price change	12.81%
3M total return	12.81%
3Y price change	138.8%
3Y return CAGR	33.66%
3Y total return	138.8%
50-day SMA	$16.47
50-day SMA vs 200-day SMA	50over200
52-week high	$19.25
52-week high date	2026-06-24
52-week low	$11.96
52-week low date	2025-10-30
5Y price change	-42.61%
5Y return CAGR	-10.51%
5Y total return	-42.61%
6M price change	4.89%
6M total return	4.89%
All-time high	$33.97
All-time high date	2021-11-03
All-time low	$1.00
All-time low date	2012-09-10
Average true range (ATR)	$0.44
Average volume	768.1K
Beta (1Y)	0.1
Beta (2Y)	0.34
Beta (5Y)	1.61
Change from 52-week high	-9.97%
Change from 52-week low	44.9%
Change from all-time high	-49.46%
Change from all-time low	1,617%
Change from open	1.11%
Day's gap	-0.64%
Dollar volume	$8.1M
High price	$17.33
Low price	$17.10
Monthly RSI	65.87
Open price	$17.14
Position in 52-week range	100%
Premarket change	0%
Premarket close	$17.25
Premarket price	$17.25
Previous close	$17.25
Price vs 150-day SMA	7.32%
Price vs 20-day SMA	3.87%
Price vs 200-day SMA	9.86%
Price vs 50-day SMA	4.22%
Relative volume	0.61
RSI	59.82
Sharpe ratio	0.97
Sharpe ratio (3Y)	0.77
Sharpe ratio (5Y)	0.2
Sortino ratio	1.71
Sortino ratio (3Y)	1.28
Sortino ratio (5Y)	0.39
Volume	466.2K
Weekly RSI	60.21
YTD price change	7.65%
YTD total return	7.65%

Metric

Value

10Y price change

441.64%

10Y return CAGR

18.41%

10Y total return

441.64%

150-day SMA

$16.00

1D price change

0.46%

1M price change

4.44%

1M total return

4.44%

1W price change

2.57%

1W total return

2.57%

1Y price change

39.71%

1Y return CAGR

39.74%

1Y total return

39.71%

20-day SMA

$16.53

200-day SMA

$15.63

3M price change

12.81%

3M total return

12.81%

3Y price change

138.8%

3Y return CAGR

33.66%

3Y total return

138.8%

50-day SMA

$16.47

50-day SMA vs 200-day SMA

50over200

52-week high

$19.25

52-week high date

2026-06-24

52-week low

$11.96

52-week low date

2025-10-30

5Y price change

-42.61%

5Y return CAGR

-10.51%

5Y total return

-42.61%

6M price change

4.89%

6M total return

4.89%

All-time high

$33.97

All-time high date

2021-11-03

All-time low

$1.00

All-time low date

2012-09-10

Average true range (ATR)

$0.44

Average volume

768.1K

Beta (1Y)

0.1

Beta (2Y)

0.34

Beta (5Y)

1.61

Change from 52-week high

-9.97%

Change from 52-week low

44.9%

Change from all-time high

-49.46%

Change from all-time low

1,617%

Change from open

1.11%

Day's gap

-0.64%

Dollar volume

$8.1M

High price

$17.33

Low price

$17.10

Monthly RSI

65.87

Open price

$17.14

Position in 52-week range

100%

Premarket change

Premarket close

$17.25

Premarket price

$17.25

Previous close

$17.25

Price vs 150-day SMA

7.32%

Price vs 20-day SMA

3.87%

Price vs 200-day SMA

9.86%

Price vs 50-day SMA

4.22%

Relative volume

0.61

RSI

59.82

Sharpe ratio

0.97

Sharpe ratio (3Y)

0.77

Sharpe ratio (5Y)

0.2

Sortino ratio

1.71

Sortino ratio (3Y)

1.28

Sortino ratio (5Y)

0.39

Volume

466.2K

Weekly RSI

60.21

YTD price change

7.65%

YTD total return

7.65%

Metric	Value
Float	129.2M
Float percentage	97.12%
Shares change (QoQ)	-2.99%
Shares change (YoY)	-5.66%
Shares held by insiders	2.19%
Shares held by institutions	64.6%
Shares outstanding	133.1M
Short % of float	6.02%
Short % of shares	5.85%
Short ratio	9.7 days

Metric

Value

Float

129.2M

Float percentage

97.12%

Shares change (QoQ)

-2.99%

Shares change (YoY)

-5.66%

Shares held by insiders

2.19%

Shares held by institutions

64.6%

Shares outstanding

133.1M

Short % of float

6.02%

Short % of shares

5.85%

Short ratio

9.7 days

Aurinia Pharmaceuticals Inc. (AUPH)

Price

Financial snapshot

Fair-value bridge

Latest news · AUPH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AUPH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AUPH

Frequently asked questions